These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 26827923

  • 21. Triboelectrification of pharmaceutical powders by particle impact.
    Watanabe H, Ghadiri M, Matsuyama T, Ding YL, Pitt KG, Maruyama H, Matsusaka S, Masuda H.
    Int J Pharm; 2007 Apr 04; 334(1-2):149-55. PubMed ID: 17141989
    [Abstract] [Full Text] [Related]

  • 22. Novel dry powder inhalation system based on dispersion of lyophilisates.
    Claus S, Schoenbrodt T, Weiler C, Friess W.
    Eur J Pharm Sci; 2011 May 18; 43(1-2):32-40. PubMed ID: 21440061
    [Abstract] [Full Text] [Related]

  • 23. Powder Flow Testing: Judicious Choice of Test Methods.
    Tay JYS, Liew CV, Heng PWS.
    AAPS PharmSciTech; 2017 Jul 18; 18(5):1843-1854. PubMed ID: 27844415
    [Abstract] [Full Text] [Related]

  • 24. Surface modification of lactose inhalation blends by moisture.
    Watling CP, Elliott JA, Scruton C, Cameron RE.
    Int J Pharm; 2010 May 31; 391(1-2):29-37. PubMed ID: 20156536
    [Abstract] [Full Text] [Related]

  • 25. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying.
    Elversson J, Millqvist-Fureby A, Alderborn G, Elofsson U.
    J Pharm Sci; 2003 Apr 31; 92(4):900-10. PubMed ID: 12661075
    [Abstract] [Full Text] [Related]

  • 26. Flowability characterisation of drug-excipient blends using a novel powder avalanching method.
    Nalluri VR, Kuentz M.
    Eur J Pharm Biopharm; 2010 Feb 31; 74(2):388-96. PubMed ID: 19796683
    [Abstract] [Full Text] [Related]

  • 27. Effect of particle properties on the flowability of ibuprofen powders.
    Liu LX, Marziano I, Bentham AC, Litster JD, White ET, Howes T.
    Int J Pharm; 2008 Oct 01; 362(1-2):109-17. PubMed ID: 18652883
    [Abstract] [Full Text] [Related]

  • 28. Powder strength distributions for understanding de-agglomeration of lactose powders.
    Das SC, Behara SR, Bulitta JB, Morton DA, Larson I, Stewart PJ.
    Pharm Res; 2012 Oct 01; 29(10):2926-35. PubMed ID: 22695732
    [Abstract] [Full Text] [Related]

  • 29. A qualitative method for monitoring of nucleation and granule growth in fluid bed wet granulation by reflectance near-infrared spectroscopy.
    Li W, Cunningham J, Rasmussen H, Winstead D.
    J Pharm Sci; 2007 Dec 01; 96(12):3470-7. PubMed ID: 17549771
    [Abstract] [Full Text] [Related]

  • 30. Insights into the roles of carrier microstructure in adhesive/carrier-based dry powder inhalation mixtures: Carrier porosity and fine particle content.
    Shalash AO, Molokhia AM, Elsayed MM.
    Eur J Pharm Biopharm; 2015 Oct 01; 96():291-303. PubMed ID: 26275831
    [Abstract] [Full Text] [Related]

  • 31. DEM analysis of the effect of particle-wall impact on the dispersion performance in carrier-based dry powder inhalers.
    Yang J, Wu CY, Adams M.
    Int J Pharm; 2015 Jun 20; 487(1-2):32-8. PubMed ID: 25845718
    [Abstract] [Full Text] [Related]

  • 32. Investigation of the milling capabilities of the F10 Fine Grind mill using Box-Behnken designs.
    Tan BM, Tay JY, Wong PM, Chan LW, Heng PW.
    Eur J Pharm Biopharm; 2015 Jan 20; 89():208-15. PubMed ID: 25497486
    [Abstract] [Full Text] [Related]

  • 33. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R, Frei M, John E, Kaerger JS.
    Int J Pharm; 2008 Feb 04; 348(1-2):10-7. PubMed ID: 17689898
    [Abstract] [Full Text] [Related]

  • 34. Understanding the influence of powder flowability, fluidization and de-agglomeration characteristics on the aerosolization of pharmaceutical model powders.
    Zhou QT, Armstrong B, Larson I, Stewart PJ, Morton DA.
    Eur J Pharm Sci; 2010 Aug 11; 40(5):412-21. PubMed ID: 20433919
    [Abstract] [Full Text] [Related]

  • 35. The influence of mechanical processing of dry powder inhaler carriers on drug aerosolization performance.
    Young PM, Chan HK, Chiou H, Edge S, Tee TH, Traini D.
    J Pharm Sci; 2007 May 11; 96(5):1331-41. PubMed ID: 17455362
    [Abstract] [Full Text] [Related]

  • 36. Application of imaging based tools for the characterisation of hollow spray dried amorphous dispersion particles.
    Gamble JF, Ferreira AP, Tobyn M, DiMemmo L, Martin K, Mathias N, Schild R, Vig B, Baumann JM, Parks S, Ashton M.
    Int J Pharm; 2014 Apr 25; 465(1-2):210-7. PubMed ID: 24508807
    [Abstract] [Full Text] [Related]

  • 37. Quantifying effects of particulate properties on powder flow properties using a ring shear tester.
    Hou H, Sun CC.
    J Pharm Sci; 2008 Sep 25; 97(9):4030-9. PubMed ID: 18228607
    [Abstract] [Full Text] [Related]

  • 38. Comparison of physical and inhalation properties of spray-dried and micronized terbutaline sulphate.
    Thi TH, Danède F, Descamps M, Flament MP.
    Eur J Pharm Biopharm; 2008 Sep 25; 70(1):380-8. PubMed ID: 18504120
    [Abstract] [Full Text] [Related]

  • 39. Understanding the effect of lactose particle size on the properties of DPI formulations using experimental design.
    Guenette E, Barrett A, Kraus D, Brody R, Harding L, Magee G.
    Int J Pharm; 2009 Oct 01; 380(1-2):80-8. PubMed ID: 19596428
    [Abstract] [Full Text] [Related]

  • 40. Application of X-ray microtomography for the characterisation of hollow polymer-stabilised spray dried amorphous dispersion particles.
    Gamble JF, Terada M, Holzner C, Lavery L, Nicholson SJ, Timmins P, Tobyn M.
    Int J Pharm; 2016 Aug 20; 510(1):1-8. PubMed ID: 27262271
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.